• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 9, 2023

    3/9/23 8:00:50 AM ET
    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Aerospace
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACHR alert in real time by email

    Companies Reporting Before The Bell

    • Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.

    • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.22 per share on revenue of $502.24 million.

    • Navios Maritime Hldgs (NYSE:NM) is expected to report earnings for its fourth quarter.

    • Fulcrum Therapeutics (NASDAQ:FULC) is projected to report quarterly loss at $0.49 per share on revenue of $1.65 million.

    • Acorda Therapeutics (NASDAQ:ACOR) is estimated to report earnings for its fourth quarter.

    • Barnes & Noble Education (NYSE:BNED) is likely to report quarterly loss at $0.16 per share on revenue of $252.67 million.

    • Aemetis (NASDAQ:AMTX) is likely to report quarterly loss at $0.25 per share on revenue of $71.44 million.

    • FuelCell Energy (NASDAQ:FCEL) is likely to report quarterly loss at $0.07 per share on revenue of $28.11 million.

    • Hut 8 Mining (NASDAQ:HUT) is projected to report quarterly loss at $0.14 per share on revenue of $25.87 million.

    • DarioHealth (NASDAQ:DRIO) is estimated to report quarterly loss at $0.65 per share on revenue of $6.29 million.

    • Aldeyra Therapeutics (NASDAQ:ALDX) is projected to report earnings for its fourth quarter.

    • Precision BioSciences (NASDAQ:DTIL) is estimated to report quarterly loss at $0.21 per share on revenue of $6.81 million.

    • Eltek (NASDAQ:ELTK) is likely to report earnings for its fourth quarter.

    • Lifetime Brands (NASDAQ:LCUT) is projected to report quarterly earnings at $0.24 per share on revenue of $201.86 million.

    • Akebia Therapeutics (NASDAQ:AKBA) is likely to report quarterly loss at $0.14 per share on revenue of $48.35 million.

    • Katapult Holdings (NASDAQ:KPLT) is projected to report quarterly earnings at $0.00 per share on revenue of $47.93 million.

    • Home Point Capital (NASDAQ:HMPT) is projected to report quarterly loss at $0.20 per share on revenue of $52.36 million.

    • Distribution Solutions (NASDAQ:DSGR) is likely to report quarterly earnings at $0.45 per share on revenue of $322.80 million.

    • Harvard Bioscience (NASDAQ:HBIO) is likely to report quarterly earnings at $0.03 per share on revenue of $30.33 million.

    • ProShares UltraShort Russell2000 (NYSE:TWM) is projected to report quarterly earnings at $0.04 per share on revenue of $500.69 million.

    • Overseas Shipholding Gr (NYSE:OSG) is expected to report earnings for its fourth quarter.

    • Docebo (NASDAQ:DCBO) is expected to report quarterly earnings at $0.02 per share on revenue of $39.40 million.

    • 22nd Century Group (NASDAQ:XXII) is likely to report quarterly loss at $0.06 per share on revenue of $20.57 million.

    • JD.com (NASDAQ:JD) is projected to report quarterly earnings at $0.51 per share on revenue of $42.96 billion.

    • Methode Electronics (NYSE:MEI) is expected to report quarterly earnings at $0.73 per share on revenue of $293.66 million.

    • Evogene (NASDAQ:EVGN) is likely to report quarterly loss at $0.20 per share on revenue of $420 thousand.

    • Duluth Holdings (NASDAQ:DLTH) is likely to report quarterly earnings at $0.65 per share on revenue of $277.65 million.

    • Global Business Travel (NYSE:GBTG) is projected to report quarterly loss at $0.15 per share on revenue of $507.06 million.

    • Solo Brands (NYSE:DTC) is estimated to report earnings for its fourth quarter.

    • Build-A-Bear Workshop (NYSE:BBW) is expected to report earnings for its fourth quarter.

    • BioXcel Therapeutics (NASDAQ:BTAI) is likely to report quarterly loss at $1.45 per share on revenue of $1.25 million.

    • Toro (NYSE:TTC) is projected to report quarterly earnings at $0.96 per share on revenue of $1.15 billion.

    • Global Indemnity Group (NYSE:GBLI) is projected to report quarterly earnings at $0.75 per share on revenue of $143.00 million.

    • Wheels Up Experience (NYSE:UP) is expected to report quarterly loss at $0.31 per share on revenue of $400.68 million.

    • Holley (NYSE:HLLY) is expected to report quarterly loss at $0.09 per share on revenue of $155.67 million.

    • John Wiley & Sons (NYSE:WLY) is projected to report quarterly earnings at $0.91 per share on revenue of $519.90 million.

    • Arrival (NASDAQ:ARVL) is expected to report earnings for its fourth quarter.

    • PowerFleet (NASDAQ:PWFL) is likely to report quarterly loss at $0.04 per share on revenue of $34.53 million.

    • Paysafe (NYSE:PSFE) is projected to report quarterly earnings at $0.05 per share on revenue of $375.25 million.

    • Village Farms Intl (NASDAQ:VFF) is estimated to report quarterly loss at $0.09 per share on revenue of $70.75 million.

    • Vital Farms (NASDAQ:VITL) is likely to report quarterly earnings at $0.04 per share on revenue of $100.29 million.

    • CareMax (NASDAQ:CMAX) is estimated to report quarterly loss at $0.05 per share on revenue of $149.38 million.

    • ANI Pharmaceuticals (NASDAQ:ANIP) is estimated to report quarterly earnings at $0.68 per share on revenue of $85.32 million.

    • BJ's Wholesale Club (NYSE:BJ) is projected to report quarterly earnings at $0.85 per share on revenue of $4.81 billion.

    • Angel Oak Mortgage (NYSE:AOMR) is estimated to report quarterly earnings at $0.31 per share on revenue of $13.73 million.

    • Arhaus (NASDAQ:ARHS) is estimated to report quarterly earnings at $0.20 per share on revenue of $348.25 million.

    • Townsquare Media (NYSE:TSQ) is projected to report quarterly earnings at $0.49 per share on revenue of $117.83 million.

    • Babylon Holdings (NYSE:BBLN) is expected to report quarterly loss at $4.42 per share on revenue of $290.38 million.

    • Broadwind (NASDAQ:BWEN) is likely to report quarterly loss at $0.15 per share on revenue of $42.70 million.

    • eMagin (AMEX:EMAN) is projected to report earnings for its fourth quarter.

    • Nano X Imaging (NASDAQ:NNOX) is estimated to report earnings for its fourth quarter.

    • AcuityAds Holdings (NASDAQ:ATY) is likely to report earnings for its fourth quarter.

    • European Wax Center (NASDAQ:EWCZ) is estimated to report earnings for its fourth quarter.

    • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its fourth quarter.

    • Genesco (NYSE:GCO) is projected to report quarterly earnings at $0.58 per share on revenue of $534.00 million.

    • Central Puerto (NYSE:CEPU) is expected to report earnings for its fourth quarter.

    Companies Reporting After The Bell

    • Frequency Electronics (NASDAQ:FEIM) is estimated to report earnings for its third quarter.

    • Regulus Therapeutics (NASDAQ:RGLS) is estimated to report earnings for its fourth quarter.

    • Entravision Comms (NYSE:EVC) is expected to report quarterly earnings at $0.19 per share on revenue of $261.45 million.

    • Molecular Partners (NASDAQ:MOLN) is estimated to report earnings for its Fiscal Year 2022.

    • Amplify Energy (NYSE:AMPY) is expected to report earnings for its fourth quarter.

    • Safeguard Scientifics (NASDAQ:SFE) is expected to report earnings for its fourth quarter.

    • Research Frontiers (NASDAQ:REFR) is expected to report earnings for its fourth quarter.

    • Hamilton Beach Brands (NYSE:HBB) is likely to report quarterly earnings at $0.97 per share on revenue of $202.60 million.

    • Cango (NYSE:CANG) is expected to report quarterly earnings at $0.04 per share on revenue of $72.24 million.

    • Helius Medical Tech (NASDAQ:HSDT) is expected to report quarterly loss at $0.13 per share on revenue of $260 thousand.

    • Douglas Elliman (NYSE:DOUG) is likely to report quarterly loss at $0.04 per share on revenue of $262.80 million.

    • Alto Ingredients (NASDAQ:ALTO) is likely to report quarterly loss at $0.06 per share on revenue of $342.43 million.

    • Inuvo (AMEX:INUV) is expected to report quarterly loss at $0.02 per share on revenue of $18.48 million.

    • AgileThought (NASDAQ:AGIL) is estimated to report quarterly loss at $0.16 per share on revenue of $42.25 million.

    • Tenon Medical (NASDAQ:TNON) is projected to report quarterly loss at $0.81 per share on revenue of $420 thousand.

    • DallasNews (NASDAQ:DALN) is estimated to report earnings for its fourth quarter.

    • Smith Micro Software (NASDAQ:SMSI) is estimated to report quarterly loss at $0.08 per share on revenue of $11.46 million.

    • iPath Series B Carbon Exchange-Traded Notes (NYSE:GRN) is projected to report quarterly loss at $0.01 per share on revenue of $20.22 million.

    • Oncternal Therapeutics (NASDAQ:ONCT) is expected to report quarterly loss at $0.21 per share on revenue of $330 thousand.

    • The One Group Hospitality (NASDAQ:STKS) is projected to report quarterly earnings at $0.16 per share on revenue of $89.73 million.

    • Oracle (NYSE:ORCL) is expected to report quarterly earnings at $1.20 per share on revenue of $12.42 billion.

    • Gritstone Bio (NASDAQ:GRTS) is expected to report quarterly loss at $0.34 per share on revenue of $2.90 million.

    • Aligos Therapeutics (NASDAQ:ALGS) is estimated to report quarterly loss at $0.47 per share on revenue of $1.72 million.

    • Guild Holdings (NYSE:GHLD) is likely to report quarterly earnings at $0.16 per share on revenue of $154.92 million.

    • aTyr Pharma (NASDAQ:LIFE) is expected to report quarterly loss at $0.48 per share on revenue of $420 thousand.

    • Lineage Cell Therapeutics (AMEX:LCTX) is projected to report quarterly loss at $0.04 per share on revenue of $2.57 million.

    • ETF Series Solutions Blue Horizon BNE ETF (NYSE:BNE) is expected to report earnings for its fourth quarter.

    • Wheaton Precious Metals (NYSE:WPM) is expected to report earnings for its fourth quarter.

    • Aqua Metals (NASDAQ:AQMS) is projected to report earnings for its fourth quarter.

    • Comtech Telecom (NASDAQ:CMTL) is expected to report quarterly loss at $0.09 per share on revenue of $133.30 million.

    • Bionano Genomics (NASDAQ:BNGO) is projected to report quarterly loss at $0.11 per share on revenue of $8.05 million.

    • Aterian (NASDAQ:ATER) is estimated to report quarterly loss at $0.27 per share on revenue of $51.81 million.

    • 360 DigiTech (NASDAQ:QFIN) is likely to report quarterly earnings at $0.49 per share on revenue of $607.98 million.

    • Aware (NASDAQ:AWRE) is likely to report quarterly loss at $0.14 per share on revenue of $3.10 million.

    • Ring Energy (AMEX:REI) is estimated to report quarterly earnings at $0.22 per share on revenue of $109.00 million.

    • Archer Aviation (NYSE:ACHR) is expected to report earnings for its fourth quarter.

    • Hydrofarm Holdings Group (NASDAQ:HYFM) is expected to report quarterly loss at $0.45 per share on revenue of $48.37 million.

    • NN (NASDAQ:NNBR) is projected to report quarterly loss at $0.02 per share on revenue of $123.30 million.

    • Alta Equipment Group (NYSE:ALTG) is expected to report earnings for its fourth quarter.

    • CytoSorbents (NASDAQ:CTSO) is likely to report quarterly loss at $0.17 per share on revenue of $8.72 million.

    • Clearside Biomedical (NASDAQ:CLSD) is estimated to report quarterly loss at $0.13 per share on revenue of $100 thousand.

    • Energous (NASDAQ:WATT) is expected to report quarterly loss at $0.07 per share on revenue of $200 thousand.

    • Limoneira (NASDAQ:LMNR) is estimated to report quarterly loss at $0.35 per share on revenue of $37.19 million.

    • Iridex (NASDAQ:IRIX) is projected to report quarterly loss at $0.11 per share on revenue of $15.16 million.

    • Concrete Pumping Holdings (NASDAQ:BBCP) is estimated to report quarterly earnings at $0.05 per share on revenue of $94.67 million.

    • Mission Produce (NASDAQ:AVO) is likely to report quarterly earnings at $0.01 per share on revenue of $207.12 million.

    • AudioEye (NASDAQ:AEYE) is expected to report quarterly loss at $0.22 per share on revenue of $7.75 million.

    • Gap (NYSE:GPS) is projected to report quarterly loss at $0.47 per share on revenue of $4.36 billion.

    • Information Servs Gr (NASDAQ:III) is estimated to report quarterly earnings at $0.11 per share on revenue of $71.22 million.

    • Velocity Financial (NYSE:VEL) is projected to report quarterly earnings at $0.29 per share on revenue of $27.70 million.

    • Adecoagro (NYSE:AGRO) is expected to report quarterly earnings at $0.20 per share on revenue of $238.00 million.

    • PlayAGS (NYSE:AGS) is likely to report quarterly loss at $0.07 per share on revenue of $78.12 million.

    • HireRight Holdings (NYSE:HRT) is likely to report quarterly earnings at $0.21 per share on revenue of $170.40 million.

    • AvePoint (NASDAQ:AVPT) is projected to report quarterly earnings at $0.01 per share on revenue of $64.02 million.

    • DocuSign (NASDAQ:DOCU) is projected to report quarterly earnings at $0.52 per share on revenue of $632.22 million.

    • Willdan Group (NASDAQ:WLDN) is projected to report quarterly earnings at $0.41 per share on revenue of $64.84 million.

    • Joint (NASDAQ:JYNT) is projected to report quarterly earnings at $0.07 per share on revenue of $27.31 million.

    • El Pollo Loco Holdings (NASDAQ:LOCO) is likely to report quarterly earnings at $0.14 per share on revenue of $115.35 million.

    • Bowman Consulting Group (NASDAQ:BWMN) is projected to report quarterly earnings at $0.15 per share on revenue of $69.86 million.

    • The Oncology Institute (NASDAQ:TOI) is estimated to report quarterly loss at $0.18 per share on revenue of $64.75 million.

    • Heritage Glb (NASDAQ:HGBL) is likely to report quarterly earnings at $0.04 per share on revenue of $10.95 million.

    • HCI Group (NYSE:HCI) is likely to report quarterly loss at $0.51 per share on revenue of $120.40 million.

    • Logan Ridge Finance (NASDAQ:LRFC) is expected to report quarterly earnings at $0.06 per share on revenue of $4.10 million.

    • Quanex Building Prods (NYSE:NX) is likely to report quarterly earnings at $0.32 per share on revenue of $269.50 million.

    • PLAYSTUDIOS (NASDAQ:MYPS) is likely to report earnings for its fourth quarter.

    • Smith & Wesson Brands (NASDAQ:SWBI) is projected to report quarterly earnings at $0.30 per share on revenue of $135.79 million.

    • Zumiez (NASDAQ:ZUMZ) is expected to report quarterly earnings at $0.03 per share on revenue of $222.00 million.

    • SpringBig Holdings (NASDAQ:SBIG) is expected to report quarterly loss at $0.12 per share on revenue of $7.40 million.

    • Rain Oncology (NASDAQ:RAIN) is estimated to report earnings for its fourth quarter.

    • a.k.a. Brands Holding (NYSE:AKA) is estimated to report quarterly earnings at $0.01 per share on revenue of $161.83 million.

    • Allbirds (NASDAQ:BIRD) is likely to report quarterly loss at $0.12 per share on revenue of $97.14 million.

    • Airgain (NASDAQ:AIRG) is projected to report quarterly earnings at $0.06 per share on revenue of $20.46 million.

    • Vail Resorts (NYSE:MTN) is projected to report quarterly earnings at $9.44 per share on revenue of $1.31 billion.

    • AppHarvest (NASDAQ:APPH) is projected to report quarterly loss at $0.35 per share on revenue of $4.20 million.

    • Jakks Pacific (NASDAQ:JAKK) is estimated to report quarterly loss at $1.37 per share on revenue of $95.00 million.

    • Ulta Beauty (NASDAQ:ULTA) is expected to report quarterly earnings at $6.50 per share on revenue of $2.48 billion.

    • Tilly's (NYSE:TLYS) is projected to report quarterly loss at $0.01 per share on revenue of $150.30 million.

    • Bakkt Hldgs (NYSE:BKKT) is likely to report quarterly loss at $0.18 per share on revenue of $16.48 million.

    • Portman Ridge Finance (NASDAQ:PTMN) is likely to report earnings for its fourth quarter.

    • HashiCorp (NASDAQ:HCP) is estimated to report quarterly loss at $0.19 per share on revenue of $129.06 million.

    • American Outdoor Brands (NASDAQ:AOUT) is projected to report quarterly earnings at $0.05 per share on revenue of $48.21 million.

    • Gevo (NASDAQ:GEVO) is likely to report quarterly loss at $0.05 per share on revenue of $2.42 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHR
    $ACOR
    $AEYE
    $AGIL

    CompanyDatePrice TargetRatingAnalyst
    Vital Farms Inc.
    $VITL
    2/27/2026$24.00Overweight → Equal-Weight
    Morgan Stanley
    Vital Farms Inc.
    $VITL
    2/27/2026$50.00 → $35.00Outperform
    Telsey Advisory Group
    Arhaus Inc.
    $ARHS
    2/27/2026$12.00 → $11.00Market Perform
    Telsey Advisory Group
    Vital Farms Inc.
    $VITL
    2/26/2026Buy → Hold
    The Benchmark Company
    Arhaus Inc.
    $ARHS
    2/26/2026$12.00 → $13.00Market Perform
    Telsey Advisory Group
    Oracle Corporation
    $ORCL
    2/25/2026$185.00Perform → Outperform
    Oppenheimer
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$33.00Buy
    Goldman
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$18.00Outperform
    Robert W. Baird
    More analyst ratings

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Jobson Charles E bought $130,874 worth of Common (15,397 units at $8.50), increasing direct ownership by 0.94% to 1,645,294 units (SEC Form 4)

    4 - JOINT Corp (0001612630) (Issuer)

    2/17/26 5:36:26 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    Chief Financial Officer Dizon Romeo R bought $2,942 worth of shares (2,200 units at $1.34), increasing direct ownership by 2% to 119,890 units (SEC Form 4)

    4 - IRIDEX CORP (0001006045) (Issuer)

    2/17/26 12:55:35 PM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Large owner Jobson Charles E bought $3,898 worth of Common (448 units at $8.70), increasing direct ownership by 0.03% to 1,639,597 units (SEC Form 4)

    4 - JOINT Corp (0001612630) (Issuer)

    2/13/26 5:16:01 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Methode Electronics Announces Third Quarter Fiscal 2026 Results Conference Call

    SOUTHFIELD, Mich., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE:MEI), a leading global supplier of custom-engineered solutions for user interface, lighting, and power distribution applications, announced it will conduct a conference call and webcast on Friday, March 6, 2026, at 11:00 a.m. EST to review its third quarter fiscal 2026 results. President and Chief Executive Officer, Jon DeGaynor, and Chief Financial Officer, Laura Kowalchik will lead the call. The presentation will be webcast live on the company's investor relations website at https://ir.methode.com. Participants are encouraged to log on to the webcast approximately 10 minutes before the start of the pres

    2/27/26 4:11:00 PM ET
    $MEI
    Electrical Products
    Technology

    Atos named a Leader in ISG Provider Lens™ 2025 for Cybersecurity – Services and Solutions in the United States

    Atos named a Leader in ISG Provider Lens™ 2025 for Cybersecurity – Services and Solutions in the United States Irving, Texas, USA – February 27, 2026 – Atos, a global leader in AI-powered digital transformation, today announced it has been named a Leader by Information Services Group (ISG) in the 2025 ISG Provider Lens™ Cybersecurity – Services and Solutions report for the United States. Atos has been ranked a Leader in the ISG Provider Lens™ for cybersecurity in the U.S. for five consecutive years (2021–2025). This latest recognition reinforces Atos' sustained leadership in the U.S. cybersecurity market. Atos was recognized as a Leader in the following three key quadrants: Next-Generat

    2/27/26 11:13:53 AM ET
    $III
    Professional Services
    Consumer Discretionary

    Willdan Selected by Mt. SAC for $49 Million Distributed Energy and Resiliency Project

    Willdan Group, Inc. (NASDAQ:WLDN) announced today that it was selected by Mt. San Antonio College (Mt. SAC) in California to implement a $49 million energy services contract. The scope of work consists of the turnkey delivery of distributed energy resources (DERs) and infrastructure upgrades, including solar PV systems, a battery energy storage system, EV charging stations, and a comprehensive parking lot redesign. Construction is expected to be completed by the third quarter of 2027. Willdan is listed as a qualified energy service company in the state of California and holds a Master Services Agreement with the Foundation for California Community Colleges to implement DERs at California

    2/27/26 9:15:00 AM ET
    $WLDN
    Military/Government/Technical
    Consumer Discretionary

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Vital Farms downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Vital Farms from Overweight to Equal-Weight and set a new price target of $24.00

    2/27/26 8:30:32 AM ET
    $VITL
    Packaged Foods
    Consumer Staples

    Telsey Advisory Group reiterated coverage on Vital Farms with a new price target

    Telsey Advisory Group reiterated coverage of Vital Farms with a rating of Outperform and set a new price target of $35.00 from $50.00 previously

    2/27/26 8:07:43 AM ET
    $VITL
    Packaged Foods
    Consumer Staples

    Telsey Advisory Group reiterated coverage on Arhaus with a new price target

    Telsey Advisory Group reiterated coverage of Arhaus with a rating of Market Perform and set a new price target of $11.00 from $12.00 previously

    2/27/26 8:02:22 AM ET
    $ARHS
    Other Specialty Stores
    Consumer Discretionary

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VAFSEO issued to AKEBIA THERAPEUTICS INC

    Submission status for AKEBIA THERAPEUTICS INC's drug VAFSEO (ORIG-1) with active ingredient VADADUSTAT has changed to 'Approval' on 03/27/2024. Application Category: NDA, Application Number: 215192, Application Classification: Type 1 - New Molecular Entity

    3/28/24 10:46:38 AM ET
    $AKBA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IGALMI issued to BIOXCEL THERAPEUTICS, INC.

    Submission status for BIOXCEL THERAPEUTICS, INC.'s drug IGALMI (ORIG-1) with active ingredient DEXMEDETOMIDINE has changed to 'Approval' on 04/05/2022. Application Category: NDA, Application Number: 215390, Application Classification: Type 3 - New Dosage Form

    4/6/22 2:18:32 PM ET
    $BTAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 18, 2022 - FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States

    For Immediate Release: February 18, 2022 Today, the U.S. Food and Drug Administration is alerting the public that several categories of FDA-regulated products purchased from Jan. 1, 2021, through the present from Family Dollar stores in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee may be unsafe for consumers to use. The impacted products originated from the company’s distribution facility in

    2/18/22 8:06:10 PM ET
    $ARVL
    Auto Manufacturing
    Consumer Discretionary

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Growth Officer Wells Meaghan Danielle was granted 829,327 shares and covered exercise/tax liability with 28,956 shares, increasing direct ownership by 152% to 1,327,052 units (SEC Form 4)

    4 - Wheels Up Experience Inc. (0001819516) (Issuer)

    2/27/26 8:08:28 PM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Chief Marketing Officer Lauria Kristen was granted 721,154 shares and covered exercise/tax liability with 39,708 shares, increasing direct ownership by 69% to 1,667,177 units (SEC Form 4)

    4 - Wheels Up Experience Inc. (0001819516) (Issuer)

    2/27/26 8:07:29 PM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Chief Legal Officer Knopf Matthew J. was granted 757,211 shares and covered exercise/tax liability with 35,728 shares, increasing direct ownership by 60% to 1,932,493 units (SEC Form 4)

    4 - Wheels Up Experience Inc. (0001819516) (Issuer)

    2/27/26 8:06:34 PM ET
    $UP
    Transportation Services
    Consumer Discretionary

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    SEC Filings

    View All

    SEC Form S-8 filed by Aldeyra Therapeutics Inc.

    S-8 - Aldeyra Therapeutics, Inc. (0001341235) (Filer)

    2/27/26 5:07:16 PM ET
    $ALDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Aldeyra Therapeutics Inc.

    10-K - Aldeyra Therapeutics, Inc. (0001341235) (Filer)

    2/27/26 4:47:10 PM ET
    $ALDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tenon Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Tenon Medical, Inc. (0001560293) (Filer)

    2/27/26 4:30:25 PM ET
    $TNON
    Medical/Dental Instruments
    Health Care

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Logan Ridge Finance Corporation

    SC 13D/A - Logan Ridge Finance Corp. (0001571329) (Subject)

    12/17/24 5:19:31 PM ET
    $LRFC
    Finance: Consumer Services
    Finance

    SEC Form SC 13G filed by DarioHealth Corp.

    SC 13G - DarioHealth Corp. (0001533998) (Subject)

    12/13/24 4:05:12 PM ET
    $DRIO
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by Hamilton Beach Brands Holding Company

    SC 13D/A - Hamilton Beach Brands Holding Co (0001709164) (Subject)

    12/10/24 5:37:18 PM ET
    $HBB
    Home Furnishings
    Consumer Discretionary

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Leadership Updates

    Live Leadership Updates

    View All

    Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale

    SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and molecular pathology laboratories in the United States, Canada and Europe describing how they envision scaling optical genome mapping (OGM), including processing up to thousands of samples per year with automation, multiple OGM systems, and VIA™ software. Other talks covered topics like Bionano's Ionic® system for isolating DNA and RNA for next generation sequencing (NGS) and advanced analytical tools that could be the future of digital cytogenetics

    2/27/26 8:00:00 AM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Paysafe Announces Changes to its Board of Directors

    New appointments bring deep expertise in global payments, digital transformation, marketing, and product innovation Paysafe (NYSE:PSFE), a leading payments platform, today announced the appointment of four new non‑executive directors to its Board, effective February 26, 2026. The new directors bring extensive expertise across global payments, financial services, technology, product innovation, and marketing leadership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227922419/en/Rupert Keeley Rupert Keeley Rupert Keeley brings significant strategic payments expertise and global regulatory insight to Paysafe. His decades of

    2/27/26 7:00:00 AM ET
    $PSFE
    Real Estate

    Establishment Labs Announces Leadership Transition to Support Next Phase of Growth

    Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced a strategic leadership transition of Raj Denhoy, current Chief Financial Officer to Senior Vice President, Global Strategy, and the appointment of Cassandra "Sandra" Harris to Senior Vice President and Chief Financial Officer, effective March 9, 2026. "Over the past few years, we have been focused on driving efficient execution and scalability. With the company well positioned for its next chapter of growth, we are creating additional leadership capacity to maintain operational momentum

    2/24/26 8:00:00 AM ET
    $ESTA
    $GCO
    Industrial Specialties
    Health Care
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ACHR
    $ACOR
    $AEYE
    $AGIL
    Financials

    Live finance-specific insights

    View All

    Methode Electronics Announces Third Quarter Fiscal 2026 Results Conference Call

    SOUTHFIELD, Mich., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE:MEI), a leading global supplier of custom-engineered solutions for user interface, lighting, and power distribution applications, announced it will conduct a conference call and webcast on Friday, March 6, 2026, at 11:00 a.m. EST to review its third quarter fiscal 2026 results. President and Chief Executive Officer, Jon DeGaynor, and Chief Financial Officer, Laura Kowalchik will lead the call. The presentation will be webcast live on the company's investor relations website at https://ir.methode.com. Participants are encouraged to log on to the webcast approximately 10 minutes before the start of the pres

    2/27/26 4:11:00 PM ET
    $MEI
    Electrical Products
    Technology

    ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Financial Guidance

    Record quarterly and full year net revenues of $247.1 million and $883.4 million, up 29.6% and 43.8% year-over-year, respectivelyTotal Rare Disease quarterly and full year net revenue of $131.3 million and $422.6 million, up 50.8% and 84.1% year-over-year, respectively Quarterly and full year Purified Cortrophin® Gel net revenues of $111.4 million and $347.8 million, up 87.6% and 75.6% year-over-year, respectivelyQuarterly and full year ILUVIEN® and YUTIQ® net revenues of $19.8 million and $74.9 million, respectively(1) Quarterly and full year GAAP net income available to common shareholders of $27.5 million and $77.2 million, respectivelyRecord quarterly and full year adjusted non-GAAP EBIT

    2/27/26 6:50:00 AM ET
    $ANIP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Docebo Reports Fourth Quarter and Fiscal Year 2025 Results

    Docebo Inc. (NASDAQ:DCBO, TSX:DCBO) ("Docebo" or the "Company"), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, announced financial results for the three months and fiscal year ended December 31, 2025. All amounts are expressed in US dollars unless otherwise stated. "Q4 was one of Docebo's strongest quarters on record, with gross bookings performance being the strongest since 2021 and Adjusted EBITDA margins reaching 21.2%, both reflecting the compounding payoff of the AI-First strategy we've been executing against," said Alessio Artuffo, President and CEO of Docebo. "The caliber of enterprise customers who chose Docebo this quarter,

    2/27/26 6:00:00 AM ET
    $DCBO
    Computer Software: Prepackaged Software
    Technology